Ravi Shukla
About Ravi Shukla
Ravi Shukla is a Principal Scientist and Senior Manager at Bristol Myers Squibb, specializing in biologic drug product manufacturing. He has extensive experience in vaccine analytics, formulation, and pharmaceutical sciences, with a Ph.D. in Pharmaceutics and Drug Design from the University of Missouri-Kansas City.
Company
Ravi Shukla is currently employed at Bristol Myers Squibb, located in New Brunswick, New Jersey, United States. He holds the position of Principal Scientist/Sr Manager - Product Champion. He started this role in August 2021. In this capacity, he leads a matrix team responsible for sterile biologic drug product manufacturing at both internal and external (CMOs) manufacturing sites.
Previous Roles at Merck
Ravi Shukla worked at Merck as a Senior Scientist in the Vaccine & Biologic Drug Product/Process Development department. He was part of the team from 2017 to 2021, a span of four years. During his tenure at Merck, Ravi gained significant experience in biologic drug product and process development.
Experience at The University of Kansas
Ravi Shukla has extensive experience in vaccine analytics and formulation from his time at The University of Kansas. He held positions as both Postdoctoral Researcher and Associate Researcher in the Vaccine Analytics and Formulation Center from 2015 to 2017. These roles allowed him to deepen his expertise in vaccine-related research.
Education and Expertise
Ravi Shukla earned a Doctor of Philosophy (Ph.D.) in Pharmaceutics and Drug Design from the University of Missouri-Kansas City, completing his studies between 2009 and 2014. His educational background in pharmaceutical sciences, combined with his practical experience, has equipped him with extensive knowledge in drug design and formulation.
Early Career and Industry Experience
Before his current role, Ravi Shukla worked at Amneal Pharmaceuticals as a Research Scientist/Scientist III in the Exploratory Preformulation R&D department from 2014 to 2015. He also has experience as a Graduate Research Assistant at the University of Missouri-Kansas City’s Division of Pharmaceutical Sciences. Additionally, he worked as a Projects Trainee at Lupin Pharmaceuticals in India in 2005, providing him with valuable international experience.